Tumba Nuhu, Adewuyi Sunday Adeyemi, Eguzo Kelechi, Adenipekun Adeniyi, Oyesegun Rasaaq
Department of Radiology, Division of Radiation/Clinical Oncology Bingham University Teaching Hospital, Jos 930214, Nigeria.
Department of Radiotherapy & Oncology Ahmadu Bello University Teaching Hospital, Zaria 810105, Nigeria.
Ecancermedicalscience. 2020 Sep 4;14:1097. doi: 10.3332/ecancer.2020.1097. eCollection 2020.
Access and availability of radiotherapy treatment is limited in most low- and middle-income countries, which leads to long waiting times and poor clinical outcomes. The aim of our study is to determine the magnitude of waiting times for radiotherapy in a resource-limited setting.
This is a retrospective cohort study of patients with the five most commonly treated cancers managed with radiotherapy between 2010 and 2014. Data includes diagnosis, patients' demographics and treatment provided. The waiting time was categorised into intervals (1) between diagnosis and first radiation consultation (2) First consultation to radiotherapy treatment (3) Decision-to-treat to treatment and (4) Diagnosis to treatment.
A total of 258 cases were involved, including cervical (50%; 129/258), breast (27.5%; 71/258), nasopharynx (12.8%; 33/258), colorectal (5%; 13/258) and prostate cancers (4.7%; 12/258). Mean age was 48 (±12.9) years. Treatment with radical intent comprised 67% (178/258) of cases, while 33% (80/258) had palliative treatment. The median time from diagnosis to first radiation consultation was 40 (IQR 17-157.75) days for all the patients, with prostate cancer having the longest time - 305 days (IQR 41-393.8). The median time between the first radiation oncology consultations and first radiotherapy treatment was 130.5 (IQR 14-211.5) days; cervical cancer patients waited a median of 139 (IQR 13-195.5) days. The median time between diagnosis and first radiotherapy for breast cancer patients was 329 (IQR 207-464) days, compared to 213 (IQR 101.5-353.5) days for all the patients.
The study shows that waiting time for radiotherapy in Nigeria was generally longer than what is recommended internationally. This reflects the need to improve access to radiotherapy in order to improve cancer treatment outcomes in resource-limited settings.
在大多数低收入和中等收入国家,放射治疗的可及性和可用性有限,这导致等待时间过长且临床结果不佳。我们研究的目的是确定在资源有限的环境中放射治疗的等待时间长度。
这是一项对2010年至2014年间接受放射治疗的五种最常见癌症患者的回顾性队列研究。数据包括诊断、患者人口统计学信息和所提供的治疗。等待时间被分为几个时间段:(1)诊断至首次放疗会诊之间;(2)首次会诊至放射治疗;(3)决定治疗至治疗;(4)诊断至治疗。
共纳入258例病例,包括宫颈癌(50%;129/258)、乳腺癌(27.5%;71/258)、鼻咽癌(12.8%;33/258)、结直肠癌(5%;13/258)和前列腺癌(4.7%;12/258)。平均年龄为48(±12.9)岁。根治性治疗的病例占67%(178/258),而33%(80/258)接受姑息治疗。所有患者从诊断到首次放疗会诊的中位时间为40(四分位间距17 - 157.75)天,前列腺癌患者的时间最长——305天(四分位间距41 - 393.8)。首次放疗肿瘤会诊与首次放射治疗之间的中位时间为130.5(四分位间距14 - 211.5)天;宫颈癌患者的中位等待时间为139(四分位间距13 - 195.5)天。乳腺癌患者从诊断到首次放疗的中位时间为329(四分位间距207 - 464)天,而所有患者的这一中位时间为213(四分位间距101.5 - 353.5)天。
该研究表明,尼日利亚放射治疗的等待时间普遍长于国际推荐时间。这反映出需要改善放射治疗的可及性,以提高资源有限环境下的癌症治疗效果。